Raja Chatterji, MD
Urogynecology and Reconstructive Pelvic Surgery · South Elgin, ILNPI 1245246065
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (54.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 62.1% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2020 at $16,914 and has fallen 98.9% since, to $182 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 125 payments — averaging $236.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$18K
- Axonics, Inc.$4K
- Medtronic$2K
- Baxter Healthcare$2K
- Boston Scientific$1K
- Applied Medical Resources Corporation$916
- plus $771 from 12 others
What the payments were for
- Consulting fees$2,0197%
- Travel & lodging$4,74916%
- Food & beverage$6,72123%
- Education$16,02554%
- Gifts$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 20 | $18,336 |
| Axonics, Inc. | 37 | $3,918 |
| Medtronic(2 entities) | 30 | $2,283 |
| Baxter Healthcare | 2 | $2,019 |
| Boston Scientific | 12 | $1,305 |
| Applied Medical Resources Corporation | 4 | $916 |
| Amgen | 3 | $252 |
| Caldera Medical, Inc | 1 | $159 |
| AbbVie | 4 | $149 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Coopersurgical, Inc. | 2 | $33 |
| Merck | 1 | $28 |
| AMAG Pharmaceuticals, Inc. | 2 | $25 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Bayer | 1 | $17 |
| Exeltis, USA Inc. | 1 | $14 |
| Ambu Inc. | 1 | $13 |
| Olympus America Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$18,251
- Axonics$3,409
- Bulkamid$2,239
- TISSEEL$2,019
- INTERSTIM$1,724
- VOYANT$875
- Solyx SIS System$484
- Prolia$231
- Advantage System$181
- Desara$159
- LYNX$150
- GENERAL PELVIC ORGAN PROLAPSE$149
- UPSYLON$146
- Orilissa$106
How this compares
$29,548 in reported general payments places this provider in the 90th percentile of 62 urogynecology and reconstructive pelvic surgery providers in Illinois.
See all urogynecology and reconstructive pelvic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 285 | $206,274 |
| GemtesaVibegron | 51 | $27,238 |
| Estradiol | 206 | $14,353 |
| Mirabegron ErMirabegron | 19 | $9,172 |
| ImvexxyEstradiol | 33 | $7,454 |
| PremarinEstrogens, Conjugated | 14 | $6,925 |
| IntrarosaPrasterone (Dhea) | 12 | $3,478 |
| Methenamine Hippurate | 15 | $886 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 62 | $644 |
| Trospium Chloride | 14 | $243 |
| Triamcinolone Acetonide | 14 | $146 |
| Ciprofloxacin Hcl | 13 | $61 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $49 | $27,23851 claims |
| AMAG Pharmaceuticals, Inc.Intrarosa | $25 | $3,47812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 62 urogynecology and reconstructive pelvic surgery providers in Illinois.
Other urogynecology and reconstructive pelvic surgery in South Elgin
- Abraham ShashouaChicago$339K
- Peter SandSkokie$185K
- Akira GillinghamChicago$58K
- Roger GoldbergSkokie$54K
- Kimberly KentonChicago$43K
- Traci BeckChicago$32K
- Margaret MuellerChicago$26K
- Lisa JohnsonOak Lawn$24K
- Henry ChillEvanston$17K
- Carol BretschneiderChicago$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.